GLUE Chart
See on advanced chart >
About
Monte Rosa Therapeutics, Inc. was incorporated under the laws of the State of Delaware in November 2019. They are a biopharmaceutical company developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to...
Read More
- HighlightA biotech company that develops novel molecular glue degrader (MGD)-based medicines
- ExchangeNASDAQ
- Listing Date06/24/2021
- Established DateInvalid Date
- Full-time Employees123
- Address645 Summer Street Suite 102 Boston Massachusetts 02210
- Tel1-617-9492643
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology
